| Patents for C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516) |
|---|
| 05/05/2011 | WO2011029639A3 Compounds and methods for treating neoplasia |
| 04/28/2011 | WO2011009529A3 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 04/27/2011 | CN102030798A Purification method of abiraterone acetate |
| 04/27/2011 | CN102030797A Technetium-labeled estradiol derivative and reference compound thereof, and preparation method, application and intermediate thereof |
| 04/27/2011 | CN101397329B Method for preparing rocuronium crystalline hydrate |
| 04/20/2011 | CN101440112B Steroid compound and use thereof |
| 04/19/2011 | US7928078 Conjugates of immune cell specific macrolide compounds with anti-inflammatory compounds for improved cellular targeting of anti-inflammatory therapy |
| 04/19/2011 | CA2486495C 9-alpha-substituted estratrienes as selectively active estrogens |
| 04/14/2011 | WO2011043913A2 Novel cationic lipids with short lipid chains for oligonucleotide delivery |
| 04/13/2011 | EP2307438A2 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 04/06/2011 | EP2305694A2 Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| 04/06/2011 | CN102002371A Liquid crystal aligning agent, liquid crystal aligning film, liquid crystal display element, compound and manufacture method of the compound |
| 03/30/2011 | CN101993470A Process for preparing high-purity rocuronium |
| 03/30/2011 | CN101182345B Ursolic acid oxazoline new drugs having antiphlogistic activity and preparation method thereof |
| 03/29/2011 | CA2622798C 17.beta.-nitro-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties |
| 03/23/2011 | CN101987862A Sulfamoyl heteroaryl carboxylic ester derivative of glucocorticoids |
| 03/17/2011 | WO2011029639A2 Compounds and methods for treating neoplasia |
| 03/09/2011 | EP1622925B1 Novel method and intermediates for the preparation of 19-nor-steroid compounds |
| 03/03/2011 | US20110054155 Novel Environmentally Friendly Technology for Production of Ginsenoside Re |
| 02/24/2011 | US20110046599 Multi-Day Delivery Of Biologically Active Substances |
| 02/23/2011 | CN101981047A Novel lupane derivatives |
| 02/22/2011 | US7893284 Oestrogen derivatives as inhibitors of steroid sulphatase |
| 02/16/2011 | CN101977924A Novel c-21-keto lupane derivatives preparation and use thereof |
| 02/10/2011 | US20110034428 Treatment of Prostate Cancer |
| 02/09/2011 | CN101970452A C20-c21 substituted glucocorticoid receptor agonists |
| 02/09/2011 | CN101967173A Novel camptothecin derivative coupled with cholic acid at position 10 |
| 02/09/2011 | CN101967172A Novel derivates of camptothecin 10-position coupled bile acid |
| 02/03/2011 | WO2010123545A3 Angiogenesis inhibitors |
| 02/02/2011 | CN101456890B Specificity inhibitor of leukaemia bcr/abl fusion gene mRNA |
| 01/27/2011 | WO2009085880A8 C-21 thioethers as glucocorticoid receptor agonists |
| 01/27/2011 | CA2768448A1 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylene oxyalkylene aryl derivatives, methods for the production thereof and the use thereof for treating diseases |
| 01/26/2011 | EP1828221B1 Pure rocuronium bromide |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/19/2011 | EP2274316A1 Ligands of estrogen receptors and , method of their preparation and pharmaceuticals comprising them |
| 01/19/2011 | CN101948500A New derivative of camptothecin 20-site coupled bile acid |
| 01/12/2011 | CN101125878B Method for preparing steroid muscle relaxants rocuronium bromide |
| 01/04/2011 | CA2520142C Oestrogen derivatives as inhibitors of steroid sulphatase |
| 12/29/2010 | EP2265628A1 Purification of air sensitive steroids |
| 12/29/2010 | CN101463063B Method for synthesizing 3 alpha-hydroxy-2 beta-amidine-5 alpha-androst-17-keto compound |
| 12/23/2010 | US20100324004 Method for Treating Diabetes |
| 12/23/2010 | US20100324003 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 12/22/2010 | CN101921597A Liquid crystal alignment agent and liquid crystal display element |
| 12/08/2010 | CN101906128A Estrone compound, as well as preparation method and application thereof |
| 12/02/2010 | WO2010136940A1 Novel glucocorticoid receptor agonists |
| 12/02/2010 | CA2760284A1 Novel glucocorticoid receptor agonists |
| 11/24/2010 | CN101891791A Derivate for labeling bile acid and reference compound, preparation method and application thereof |
| 11/17/2010 | EP2250185A1 Novel lupane derivatives |
| 11/16/2010 | CA2185123C Steroid derivatives, pharmaceutical compositions containing them, and their pharmaceutical uses |
| 11/04/2010 | WO2010126953A1 Corticosteroid linked beta-agonist compounds for use in therapy |
| 11/03/2010 | EP2245042A1 C20-c21 substituted glucocorticoid receptor agonists |
| 10/28/2010 | WO2010123545A2 Angiogenesis inhibitors |
| 10/21/2010 | WO2010118699A1 High purified (2β,3α,5α,16β,17β) -2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition containing it and its preparation method |
| 10/20/2010 | CN101863948A High-purity (2 beta, 3 alpha, 5 alpha, 16 beta, 17 beta)-2-(4-morpholinyl)-16-(1-pyrrolidinyl)-androstane-3,17-diol or composition thereof and preparation method thereof |
| 10/19/2010 | US7816348 2-amido-5-oxo/thio-benzoic acid derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 10/14/2010 | WO2010118025A1 Progesterone antagonists spiro condensed in position 17 with a difluoromethylene- substituted perhydrofurane group |
| 10/14/2010 | US20100261167 In vivo screen using chemical inducers of dimerization |
| 10/13/2010 | CN101861328A Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 10/06/2010 | EP2235035A2 C-21 thioethers as glucocorticoid receptor agonists |
| 09/16/2010 | WO2010102673A1 Hellebrin and hellebrigenin derivatives |
| 09/08/2010 | CN101824066A Method for preparing rocuronium bromide midbody compound crystal |
| 09/01/2010 | CN101821671A Liquid crystal aligning agent, method for producing liquid crystal alignment film, and liquid crystal display device |
| 08/31/2010 | US7786102 Steroids as agonists for FXR |
| 08/12/2010 | WO2010091306A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| 08/12/2010 | WO2010091303A1 Novel steroidal cyp17 inhibitors/antiandrogens |
| 08/12/2010 | CA2761389A1 Novel prodrugs of steroidal cyp17 inhibitors/antiandrogens |
| 08/10/2010 | US7772218 Synthesis of steroids, especially 3-hydroxy-7 alpha -methyl-21-[2'-methoxy-4'-(diethylaminomethyl)-phenoxy]-19-norpregna-1,3,5(10)triene citrate and treatment of prostate disorders such as prostatic cancer. |
| 07/28/2010 | EP2209795A1 Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders |
| 07/28/2010 | CN101035801B Method for synthesizing quaternary ammonio-sterods |
| 07/14/2010 | EP2206719A2 Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens: Synthesis, In Vitro Biological Activities, Pharmacokinetics and Antitumor |
| 07/14/2010 | CN101775062A Cationic lipid containing carbamate and cyclic polyamine, transgenic vector and preparation method |
| 07/07/2010 | CN101768199A Polymorphs of abiraterone acetate and preparation method thereof |
| 07/01/2010 | US20100168052 Treatment of EBV and KHSV Infection and Associated Abnormal Cellular Proliferation |
| 06/30/2010 | CN101759754A Synthetic method of beta-Sitosterol Nicotinate |
| 06/22/2010 | CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens |
| 06/17/2010 | US20100152437 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 06/16/2010 | EP2196469A1 Conjugates with anti-inflammatory activity |
| 06/16/2010 | CN101732730A Cation lipid containing imidazolium salt and macrocyclic polyamines, transgenetic vector and method for preparing same |
| 06/08/2010 | US7732432 such as (11 beta ,16 beta)-9-fluoro-11,21-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl ethylcarbamate, having potent antiinflammatory and immunosuppressive activity and possess advantages over steroidal glucocorticoid ligands with respect to side effects, efficacy, toxicity and/or metabolism |
| 06/03/2010 | WO2010062562A1 Synthesis and use of cationic steroids for anti-inflammatory drug therapy |
| 06/03/2010 | WO2010060215A1 2-(n-substituted piperazinyl) steroid derivatives |
| 06/03/2010 | CA2744369A1 2-(n-substituted piperazinyl) steroid derivatives |
| 06/02/2010 | EP1438299B1 Bifunctional chelating agent for actinium |
| 06/01/2010 | CA2440680C Steroids as agonists for fxr |
| 05/27/2010 | US20100129842 Isobarically labeled analytes and fragment ions derived therefrom |
| 05/26/2010 | EP2188299A2 A method for treating diabetes |
| 05/26/2010 | CN101712713A Steroid cholic acid-quinacridone derivative and gel thereof |
| 05/12/2010 | CN101704871A Steroid compound and application thereof |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2089376C Sugar modified oligonucleotides that detect and modulate gene expression |
| 04/29/2010 | US20100105892 Purification process comprising dissolving an organic compound in carbonated water and freeze-drying |
| 04/22/2010 | WO2010012904A3 Novel cholest-4-en-3-one oxime derivatives, pharmaceutical compositions containing same, and preparation method |
| 04/20/2010 | US7700766 Methanesulfonate salts of abiraterone-3-esters and recovery of salts of abirater one-3-esters from solution in methyl tert-butyl ether |
| 04/06/2010 | US7691836 Progesterone receptor modulators |
| 03/31/2010 | CN101687905A Pure rocuronium bromide |
| 03/31/2010 | CN101684139A Synthesis process of vecuronium bromide |
| 03/30/2010 | US7687486 Selective estrogen receptor modulators |
| 03/10/2010 | EP1023315B1 Methods and compositions for destruction of selected proteins |
| 03/04/2010 | WO2009120565A3 Novel prodrugs of c-17-heteroaryl steroidal cyp17 inhibitors/antiandrogens: synthesis, in vitro biological activities, pharmacokinetics and antitumor activity |
| 03/02/2010 | US7671045 carcinoma and adenocarcinomas of the breast; Type II diabetes mellitus; 19,24-Dinorchola-4,9,20-trien-3-one, 17,23-epoxy-11-[4-(5,5-Dimethyl-2-oxo-2 lambda 5-[1,3,2]dioxaphosphinan-2-yl)-phenyl]-, (11 beta ,17 alpha )-(9Cl) |
| 02/25/2010 | US20100048888 Lipid Nanoparticle Based Compositions and Methods for the Delivery of Biologically Active Molecules |